BioSpace News Archive

Nanion is pleased to announce the launch of the SyncroPatch 384i. This new giga-ohm seal HTS automated patch clamp platform provides effortless ion channel screening coupled with unmatched flexibility, ease-of-use and reliability

Quanta, Inc. (OTC: QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within the human body, announced today that Dr. Arthur Mikaelian, founder of the patented polarization technology utilized by Quanta, has officially become the companies’ Chief Science Officer.

According to Coherent Market Insights, the global custom recombinant protein production services market was valued at US$ 2,600.21 million in 2017, and is projected to exhibit a CAGR of 11.2% over the forecast period (2018 – 2026).

Taro Pharmaceutical Industries Ltd. (NYSE: TARO, “Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2019, filed with the Securities and Exchange Commission (the “SEC”), is available within the Investor Relations section of Taro’s website at www.taro.com.

California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, today announced a new life sciences credit card member benefit through its partnership with Brex, the corporate card built for the life sciences that accelerates entrepreneurs and scaling businesses.

Heart Valve Voice US (HVV), the leading patient advocate group for people living with heart valve disease, says new research on the benefits of transaortic valve replacement (TAVR) should be a major consideration for the Centers for Medicare and Medicaid Services as they determine how they will cover TAVR.

According to Coherent Market Insights, the global oral biologics market was valued at US$ 834.3 million in 2018, and is projected to exhibit a CAGR of 32.8% over the forecast period (2018–2026)

SOFIE Inc. (SOFIE), a Theranostics company, is pleased to announce an exclusive global license with University Clinic Heidelberg (UKHD) for a class of molecular targeted diagnostics and radiotherapeutics (“theranostics”) that are designed to identify and break down cancer associated fibroblasts in tumor stroma and irradiate nearby cancer cells.

ACT uses an unconventional approach to create awareness around anonymous HIV testing. 51% of people living with HIV in Canada are gay or bisexual men.

Ra Medical Systems, Inc. (NYSE: RMED) announced two live cases and an expert panel presentation of clinical outcomes utilizing DABRA for the treatment of peripheral artery disease (PAD) to occur at the C3 Global Summit.